Citation Impact
Citing Papers
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Microbiota in health and diseases
2022 Standout
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
2021
Long COVID: major findings, mechanisms and recommendations
2023 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD
2018
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
2020
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
2016
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
2014
Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
2017
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
2022
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
2016
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
2021
Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology
2021
Nrf2 attenuates inflammatory response in COPD /emphysema: Crosstalk with Wnt3a/β‐catenin and AMPK pathways
2018 Standout
Works of Simon Brill being referenced
Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease
2014
Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
2014
COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease
2020
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
2013
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
2015
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
2020
Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease
2015